Consider a Fixed Dose of Rasburicase for Tumor Lysis Syndrome

December 2017

We're getting questions about rasburicase (Elitek) and other treatments for tumor lysis syndrome (TLS)...a common oncological emergency.

When dying cancer cells spill their contents, it can cause high levels of potassium, phosphorus, and uric acid...plus low calcium.

Consider patients to have active TLS when at least two of these lab abnormalities are present just before or after cancer treatment.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote